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Abstract
OBJECTIVE: To explore the characteristics of blood
glucose excursions of type 2 diabetes mellitus pa-
tients with three different Traditional Chinese Medi-
cine (TCM) syndromes.
METHODS: One hundred and nine patients with
type 2 diabetes mellitus were recruited from the
Department of Endocrinology and the Department
of TCM of the Sixth People's Hospital affiliated to
Shanghai Jiao Tong University. Subjects were divid-
ed into three groups according to TCM syndrome:
intrinsic Damp (n = 42), Yin deficiency and internal
Heat (n = 25), and Qi and Yin deficiency (n = 42).
Subcutaneous interstitial glucose was monitored
with a continuous glucose monitoring system for 3
consecutive days to investigate the glycemic pro-
file in each group. Plasma C-peptide levels were
measured, and an arginine test was taken in 10 pa-
tients randomly selected from each group. Glucose
data and glycemic variability were analyzed to in-
vestigate the differences among the groups. The
change in C-peptide levels and the results from ar-
ginine trial were used to evaluate β cell function.
RESULTS: Indicators reflecting blood glucose level
were the highest in subjects with Yin deficiency
and internal Heat syndrome, and parameters re-
flecting glycemic variability were the lowest in
those with Qi and Yin deficiency syndrome. The
change in C-peptide levels showed that subjects
with Qi and Yin deficiency syndrome had the best β
cell function among the three groups; this was con-
firmed by the arginine trial.
CONCLUSION: Patients with Qi and Yin deficiency
syndrome had a more stable blood glucose profile,
as glycemic variability was higher in those with in-
trinsic Damp syndrome and those with Yin deficien-
cy and internal Heat syndrome.
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INTRODUCTION
The incidence of type 2 diabetes mellitus (T2DM) is
increasing every year, becoming the third biggest killer
of humans following cancer and cardiovascular disease.1,2
Moreover, T2DM is closely related to the occurrence
of cancer and cardiovascular disease.3 Therefore, more
attention worldwide has been paid to T2DM in recent
years. Recognizing the characteristics of the blood glu-
cose (BG) profile is necessary for doctors and patients
to control BG and delay complications of T2DM both
in Western Medicine and Traditional Chinese Medi-
cine (TCM).
The effect of the T2DM treatment regimen is usually
assessed by measuring fasting BG and postprandial BG
levels, which can only reflect the instant BG level; how-
ever, glycolated hemoglobin (HBA1C) reflects the aver-
age BG level of the previous 2-3 months.4 The continu-
ous glucose monitoring system (CGMS) is a new tech-
nology applied in clinical practice that can provide a
continuous glycemic profile and best reflect the individ-
uals' current BG status.5 Doctors can then use this
CGMS profile to design the optimal individual treat-
ment regimen. Many previous studies have demonstrat-
ed that BG variability rather than hyperglycemia alone
contributes to chronic complications in diabetes pa-
tients;6 hence, the importance of lowering BG stably
rather than quickly has been emphasized in recent
years.
Modern medicine can control BG levels, but it has lim-
ited effects on improving patients' symptoms and con-
trolling complications. TCM treatment is chosen ac-
cording to TCM syndrome differentiation, and plays
an important role in the treatment of T2DM and its
complications in China.7 Diabetes has a long history in
TCM, and was first discussed in the book Huang Di
Nei Jing under the name of Xiaoke.8 Chinese doctors
in ancient years thought that Yin deficiency and dry
Heat were the pathogenesis of diabetes accompanied
by symptoms of large intake of food and drink, poly-
uria, and emaciation. However, changes in lifestyle and
environment are changing the symptoms of diabetes,
especially T2DM and its TCM syndrome differentia-
tion. Currently, internal Damp and Blood stasis play
an important role in the development of T2DM.9
Different clinical manifestations can be found in differ-
ent T2DM patients in clinical practice. For example,
some individuals suffer from diabetes without discom-
fort, while others manifest with typical symptoms. Pre-
vious CGMS studies have demonstrated that glycemic
profiles differ from person to person.10,11 Thus, in this
study we selected three types of common T2DM TCM
syndromes, including intrinsic Damp syndrome, Yin
deficiency and internal Heat syndrome, and Qi and
Yin deficiency syndrome. Intrinsic Damp syndrome
manifests as a heavy sensation of the body and limbs,
abdominal distention, oppressed feelings in the chest,
poor appetite, a sticky and greasy tongue with a
white-thick coating, and a slippery pulse. Yin deficien-
cy and internal Heat syndrome manifests as overeating
and large appetite, thirst and excessive cold drinking,
vexation, sensitivity to heat, insomnia, dry stool, yel-
low urine with constipation, a red tongue with yellow
coating, and a fast and stringy pulse. Qi and Yin defi-
ciency syndrome manifests as tiredness, spontaneous
sweating, shortness of breath, thirst and excessive drink-
ing, dysphoria with a hot sensation in the chest, palms
and soles, palpitations and insomnia, red tongue with
little or no coating, and a thready and weak pulse or a
stringy and weak pulse. We explored the relationship
between BG profile and TCM syndrome differentia-
tion, expecting to provide evidence and instructions
for selection of prescriptions in TCM clinical practice.
MATERIALS ANDMETHODS
Subjects
We recruited 109 in-patients from the Department of
Endocrinology and the Department of TCM at the
Sixth People's Hospital affiliated to Shanghai Jiao Tong
University between 1 January 2012 and 30 June 2013.
All patients gave informed consent, and the trial was
approved by the Ethics Committee of the Sixth Peo-
ple's Hospital affiliated to Shanghai Jiao Tong Universi-
ty. The subjects were divided into three groups: group
1 included those with intrinsic Damp syndrome (n =
42), group 2 included those with Yin deficiency and in-
ternal Heat syndrome (n = 25), and group 3 included
those with Qi and Yin deficiency syndrome (n = 42).
Standard of diagnosis
T2DM was diagnosed according to the 1999 World
Health Organization (WHO) criteria.12 TCM diabetes
was diagnosed according to the standard in the 2002
Guidelines for Clinical Research into New Chinese
Drugs.13
Inclusion criteria
T2DM patients aged 20-80 years were eligible for en-
rollment in this study if they were diagnosed with in-
trinsic Damp syndrome, Yin deficiency and internal
Heat syndrome, or Qi and Yin deficiency syndrome ac-
cording to TCM syndrome differentiation, and volun-
tarily agreed to take part in clinical observation. Addi-
tionally, only those who had not changed their treat-
ment regimen in the previous 3 months were selected.
All study subjects must not have changed their therapy
until the CGMS was removed.
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Exclusion criteria
(a) Patients aged ≥ 80 years or ≤ 20 years. (b) Acute
complications including diabetic ketoacidosis and hy-
perglycemic hyperosmolar state in the previous month.
(c) History of hepatic or renal impairment. (d) Other
diseases which can influence glucose metabolism such
as recent acute cerebral stoke, acute myocardial infarc-
tion, malnutrition, cancers and infections. (e) Patients
who had changed their glucose-lowering regimen in
the previous 3 months. (f ) Patients who were unwilling
to cooperate, such as those with mental disease. (g) Pa-
tients using drugs that influence glucose metabolism,
such as hormones. (h) Patients diagnosed with other
types of TCM syndromes.
Measurements and parameters
Study subjects were given a physical examination in-
cluding measurement of height, weight, waist circum-
ference, and hip circumference. Body mass index
(BMI) was calculated as weight in kg divided by height
in m2. Blood pressure was measured in an air-condi-
tioned, quiet room by using a mercury sphygmoma-
nometer (OMRON Co., Ltd., Dalian, China); the av-
erage of three measurements taken at 2 min intervals
was used for analysis.
The sensor of a retrospective CGMS was inserted, then
removed after 72 h, generating a daily record of 288
continuous sensor values taken at 5 min intervals over
24 h. The CGMS was calibrated daily by entering a
minimum of four capillary BG readings measured with
a SureStep BG meter (LifeScan, Milpitas, CA, USA). A
venous blood sample was drawn at 6am after a 10 h
overnight fast to measure biochemical indicators, in-
cluding hepatic biomarkers such as alanine aminotrans-
ferase (ALT), aspartate aminotransferase (AST), and re-
nal function biomarkers such as blood urea nitrogen
(BUN), plasma creatinine (Cr), and uric acid (UA). To-
tal cholesterol (TC), triglycerides (TG), high density li-
poprotein cholesterol (HDL-C), low density lipopro-
tein cholesterol (LDL-C), fasting plasma glucose
(FPG), 30 min postprandial plasma glucose (30PG),
120 min postprandial plasma glucose (120PG),
HBA1C, and glycated albumin (GA) were also mea-
sured. Fasting C-peptide (FCp), 30 min postprandial
C-peptide (30Cp), and 120 min postprandial C-pep-
tide (120Cp) were monitored to evaluate β cell func-
tion. Ten individuals were selected randomly from each
group to take an arginine test in order to accurately de-
termine the β cell function of the pancreatic islets. The
24 h mean BG (MBG) level, total time in min in
which subcutaneous glucose was over 10 mmol/L or
less than 4 mmol/L, the maximum glucose level and
the minimum glucose level were recorded to assess BG
level. The standard deviation of BG values (SDBG),
the mean amplitude of glycemic excursions (MAGE),
mean of daily difference (MODD), and the large am-
plitude of glycemic excursions (LAGE) were calculated
to estimate the state of glycemic variability.
Statistical analysis
All data were analyzed using the Statistical Package for
Social Sciences 17.0 (SPSS Inc., Chicago, IL, USA).
Qualitative data are expressed as mean ± standard devi-
ation ( xˉ ± s). The Kolmogorove-Smirnov normality
test was done, and one-way analysis of variance (ANO-
VA) was employed if the data were normally distribut-
ed; the lowest significant difference or Student-New-
man-Keuls multiple comparison in ANOVA was used
to explore the difference between two groups. The rank
sum test was used if the data were not normally distrib-
uted. Comparison of categorical variables was done us-
ing the χ2 test; χ2 was used when the minimum expect-
ed count T ≥ 5, continuity correlation χ2 was used
when 1 ≤ T < 5, and Fisher's exact probability test was
used when T < 1 or 0 appeared in the actual frequency.
P < 0.05 was considered to denote statistically signifi-
cant differences.
RESULTS
Baseline data
Characteristics of the patients in each group are shown
in Table 1. Individuals in group 3 were much younger
than those in group 2, and those in group 1 had the
largest mean BMI and the highest mean systolic blood
pressure compared with individuals in the other two
groups (Table 1). Moreover, the mean TC in group 1
was significantly higher than that in groups 2 and 3
(all P < 0.05), and the mean blood UA was significant-
ly higher in group 1 than in group 2 and 3 (P < 0.01,
P < 0.05 respectively). In addition, there was a signifi-
cant difference in mean ALT between patients in group
3 and those in the other two groups (all P < 0.05).
All patients being treated with insulin were using pre-
mixed insulin (Novolin 30R or Humulin 70/30) twice
daily, before breakfast and before supper. Patients in
the three groups were mainly treated with insulin and
two kinds of oral hypoglycemic drugs (Table 2). Pa-
tients in group 2 were commonly using insulin com-
bined with α-glucosidase inhibitors (α-GI) and sulfo-
nylurea (SU), with fewer patients using metformin.
More patients in group 1 were using statins to lower
cholesterol compared with group 2 (P < 0.01).
Blood glucose level
Almost all indicators were normally distributed, except
for time of BG < 4 mmol/L. FPG and 120PG were sig-
nificantly higher in group 2 and significantly lower in
group 3 among the three groups (all P < 0.01). 30PG
and HBA1C were highest in group 2, although no sig-
nificant differences in these two parameters were found
between groups 1 and 3. GA in group 3 was much
higher than in group 2, but there was no significant dif-
ference between GA in group 1 and the other two
groups (P > 0.05). MBG, maximum BG, and time of
BG > 10 mmol/L in group 2 were significantly higher
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Table 2 Specific medication uses in each group (n)
Notes: group 1: intrinsic damp syndrome group; group 2: Yin deficiency and internal heat syndrome group; group 3: Qi deficiency and
Yin deficiency syndrome group. As enrolled patients had a long duration of type 2 diabetes mellitus, all patients had been treated with insu-
lin; no patients was being treated with oral hypoglycemic drugs alone. INS: insulin; α-GI: α-glucosidase inhibitors; SU: sulfonylurea;
INS1: insulin and α-GI and metformin; INS2: insulin and α-GI and SU; INS3: insulin and metformin and SU; INS4: insulin and α-GI
and metformin and SU. aP < 0.01, and bP < 0.05, compared with group 2. cP < 0.01, and dP < 0.05, compared with group 1.
Item
Hypoglycemic medication use
Lipid lowering medication use
Medication use
INS
INS+α-GI
INS+metformin
INS+SU
INS1
INS2
INS3
INS4
Total
Statins
Fibrates
Total
Group 1 (n = 42)
0
4
8
4
12a
3b
7
4
42
33b
2
35
Group 2 (n = 25)
0
3
1
3
2c
11d
3
2
25
11d
0
11
Group 3 (n = 42)
2
7
3
5
10a
8a
5
2
42
29
0
29
Total
2
14
12
12
24
22
15
8
109
73
2
75
Characteristic
Male/Female (n)
Age (years)
Height (cm)
Weight (kg)
BMI (kg/m2)
WC (cm)
HC (cm)
SBP (mm Hg)
DBP (mm Hg)
History of high BP (years)
Diabetes Duration (years)
TC (mmol/L)
TG (mmol/L)
HDL (mmol/L)
LDL (mmol/L)
ALT (u/L)
AST (u/L)
BUN (mmol/L）
Cr (μmmol/L)
UA (μmmol/L)
Group 1 (n = 42)
18/24
57.15±8.32
163.5±7.83
68.78±10.19a
25.73±3.35b
92.98±10.38
99.17±7.38
137.84±19.47b
80.92±13.04
10.40±9.42
10.84±6.82
4.50±1.32
2.36±1.75a
0.99±0.21
2.55±0.88
19.13±10.14
19.18±5.80
4.85±1.90
64.36±20.13
319.56±52.35b
Group 2 (n = 25)
12/13
60.36±8.97
164.36±8.67
62.52±10.00c
22.78±2.14d
88.35±7.13
95.40±5.64
127.04±13.87d
78.72±7.79
8.50±9.20
11.21±7.26
4.56±1.00
1.57±0.62c
0.95±0.23
2.55±0.88
18.68±7.59
17.28±5.65
5.42±1.97
75.80±39.94
272.50±55.49d
Group 3 (n = 42)
27/15
54.95±11.90a
165.98±9.15
65.81±10.39
24.01±3.33c
90.25±10.32
94.78±11.41c
127.52±12.87d
79.86±10.59
16.00±13.11
10.66±7.48
4.36±0.72
1.63±1.06c
1.04±0.30
2.59±0.58
26.69±18.04ac
21.90±8.78a
4.95±1.94
69.78±24.89
288.68±64.87c
Notes: group 1: intrinsic damp syndrome group; group 2: Yin deficiency and internal heat syndrome group; group 3: Qi deficiency and
Yin deficiency syndrome group. As enrolled patients had a long duration of type 2 diabetes mellitus, all patients had been treated with insu-
lin; no patient was being treated with oral hypoglycemic drugs alone. BMI: body mass index; WC: waist circumference; HC: hip circum-
ference; BP: blood pressure; SBP: systolic blood pressure; DBP: diastolic blood pressure; TC: total cholesterol; TG: triglycerides; HDL-C:
high density lipoprotein cholesterol; LDL-C: low density lipoprotein cholesterol; ALT: alanine aminotransferase; AST: aspartate amino-
transferase; BUN: blood urea nitrogen; Cr: plasma creatinine; UA: uric acid. aP < 0.05, and bP < 0.01, compared with group 2. cP < 0.05,
and dP < 0.01, compared with group 1.
Table 1 Characteristics of patients with type 2 diabetes in each group ( xˉ ± s)
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than the other two groups, and significant differences
were found between any two groups of the three (all
P < 0.01). In group 2, the minimum BG was higher
and time of BG < 4 mmol/L was less than the other
two groups, although no significant difference was
found between groups 1 and 3 (Table 3).
Glycemic variability
Data regarding indicators were normally distributed in
group 2 and group 3, except for low BG index (LBGI).
The SD, LAGE, MAGE, MODD, and M values were
used to determine the state of BG fluctuations. The
abovementioned parameters that reflect glycemic vari-
ability and the instability index (II), which is data
standing the state of glucose instability, were all sig-
nificantly lower in group 3 than the other two
groups (Table 3, all P < 0.01). The LBGI in
group 2 was significantly lower than in groups 1
and 3 (P < 0.01, P < 0.05 respectively), and the
high BG index (HBGI) was highest in group 2. Gly-
cemic risk assessment in diabetes equation (GRADE)
was the indicator used to evaluate the risk of T2DM
patients developing acute and chronic complications;
the GRADE of group 2 > group 1 > group 3. Specif-
ic situations of glycemic variability in each group are
shown in Table 4.
Characteristic
FPG (mmol/L)
30PG (mmol/L)
120PG (mmol/L)
HBA1C (%)
GA (%)
MBG (mmol/L)
Maximum of BG (mmol/L)
Minimum of BG (mmol/L)
Time of BG > 10 mmol/l (min)
Time of BG < 4 mmol/L(min)
Group 1 (n = 42)
8.2±2.8a
10.8±3.1b
13.4±3.7a
8.7±1.8b
20.9±5.8
9.8±2.1a
16.4±3.1a
4.6±1.7a
626.7±320.8a
36.3±82.7b
Group 2 (n = 25)
9.8±2.7c
12.9±3.7d
16.2±3.5c
9.7±1.7d
23.4±5.2
11.4±2.0c
18.2±2.5c
6.5±2.2c
860.8±312.2c
4.2±23.9d
Group 3 (n = 42)
7.0±1.7ad
9.5±2.5a
10.6±3.6ac
8.1±1.9a
18.5±5.4a
8.0±1.4ac
13.1±2.6ac
4.8±1.3a
243.6±223.2ac
36.1±89.3b
Table 3 Characteristics of blood glucose in the three groups ( xˉ ± s)
Notes: group 1: intrinsic Damp syndrome group; group 2: Yin deficiency and internal Heat syndrome group; group 3: Qi deficiency and
Yin deficiency syndrome group. As the enrolled patients had a long duration of type 2 diabetes mellitus, all patients were being treated
with insulin; no patient was being treated with oral hypoglycemic drugs alone. FPG: fasting plasma glucose; 30PG: 30 min postprandial
plasma glucose; 120PG: 120 min postprandial plasma glucose; HBA1C: glycolated hemoglobin; GA: glycated albumin; BG: blood glu-
cose; MBG: 24 h mean blood glucose. Indicators in Table 3 were normally distributed, except for time of BG < 4 mmol/L, so the rank
sum test was used to compare time of BG < 4 mmol/L between two groups. aP < 0.01, and bP < 0.05, compared with group 2; cP < 0.01,
and dP < 0.05, compared with group 1.
Characteristic
SD
LAGE (mmol/L)
MAGE (mmol/L)
MODD (mmol/L)
II [(mmol/L)2/L per day]
LBGI
HBGI
GRADE
M value
Group 1 (n = 42)
2.8±1.0
11.7±3.4
6.8±3.1
2.8±1.0
5.3±3.7
3.1±3.4a
11.1±6.1b
9.6±5.3a
19.9±16.1b
Group 2 (n = 25)
3.0±0.9
11.7±2.9
7.2±2.5
3.0±1.0
4.5±1.6
0.7±1.3c
15.0±6.5d
13.1±4.7c
30.1±17.6d
Group 3 (n = 42)
1.9±0.7ac
8.3±2.7ac
5.2±2.4ac
2.0±0. 8ac
3.2±2.2ac
1.9±3.1b
4.9±3.2ac
5.1±2.9ac
7.1±6.1ac
Table 4 Characteristics of glycemic variability in the three groups ( xˉ ± s)
Notes: group 1: intrinsic damp syndrome group; group 2: Yin deficiency and internal heat syndrome group; group 3: Qi deficiency and
Yin deficiency syndrome group. As enrolled patients had a long duration of type 2 diabetes mellitus, all patients had been treated with insu-
lin; no patient was being treated with oral hypoglycemic drugs alone. SDBG: standard deviation of blood glucose values; MAGE: mean
amplitude of glycemic excursions; MODD: mean of daily difference; LAGE: large amplitude of glycemic excursions; II: instability index;
LBGI: low blood glucose index; HBGI: high blood glucose index; GRADE: glycemic risk assessment in diabetes equation. LBGI data were
not normally distributed in group 2 and group 3, so the rank sum test was used to compare the indicator among groups. aP < 0.01, and
bP < 0.05, compared with group 2; cP < 0.01 and dP < 0.05, compared with group 1.
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β cell function
The β cell function data distribution was normal (Ta-
ble 5). The change in the C-peptide value (△Cp) was
used to make a simple evaluation about β cell func-
tion. The increase in 30 Cp was less than that in
120Cp (Table 4). No significant difference was found
in FCp or 30 Cp among the three groups; however, the
FCp in group 1 seemed higher than the other two
groups, and the level of 120 Cp in group 3 was the
highest among the three groups (all P < 0.05). The in-
crease in C-peptide after 120 min (△Cp120) in group
3 was significantly higher than in groups 1 and 2 (all
P < 0.05). In order to obtain acute results regarding β
cell function, we selected 10 patients randomly in each
group using a lottery method to take an arginine trial;
the results of this showed that patients in group 1 had
the worst β cell function, and the best β function was
in group 3. Beta cell function in group 3 > group 2 >
group 1 (Figure 1, Table 5).
DISCUSSION
Recognition of diabetes mellitus (DM) in TCM origi-
nated from the Su Wen, and was termed xiaoke;14 the
disease manifested as large intake of food and drink,
polyuria, and emaciation. TCM explores the occur-
rence of DM in terms of cause, onset, pathogenesis, dis-
ease characteristics, and relationship between evil Qi
and vital energy.15 In TCM, DM is an individualized
disease caused by Yin deficiency and dry Heat, with
Yin deficiency as the basis of the disease. However, in
recent years, an increasing number of TCM doctors
have considered that DM was a part of Xiaoke that can-
not summarize the whole features of DM. In other
words, one part of DM can be treated as xiaoke, but
the other part cannot. For example, patients who have
a rise in BG according to the diagnostic criteria for
DM in modern medicine but do not have diabetic
symptoms are beyond the scope of xiaoke. Thus, mod-
ern TCM doctors have different viewpoints in recogniz-
ing DM from TCM doctors in ancient years.
Given that syndrome differentiation is the essence of
TCM, DM patients are always classified into kinds of
syndromes to allow individual treatment in TCM clini-
cal practice. While it was previously thought that Yin
deficiency and internal Heat was the most common
syndrome of DM, doctors in clinical practice have
found that intrinsic Damp syndrome is playing a more
important role in development of the disease in recent
years.9 Moreover, many studies have reported that in-
trinsic Damp syndrome is now one of the most com-
mon syndromes in DM, accounting for 14.1% of all
TCM syndromes in DM patients.16 The importance of
invigorating the Spleen has been emphasized in clinical
TCM,17 which further indicates that internal wetness
plays an important role in DM as Damp always results
from deficiency of the Spleen.
In this study, three common TCM syndromes in DM
patients including Qi and Yin deficiency syndrome,
Yin deficiency and internal Heat syndrome, and intrin-
sic Damp syndrome were selected to explore the glyce-
mic features of different syndromes. CGMS measure-
ments showed that the BG profile of T2DM patients
with Qi and Yin deficiency syndrome was more stable
and had the lowest level of glycemic variability, while
patients in the other two groups had fluctuating BG
profiles. In addition, the MBG of subjects with Yin de-
ficiency and internal Heat syndrome was the highest
among the three groups.
C-peptide is a product of proinsulin decomposition;
hence, the △Cp was used to assess the β cell func-
tion of T2DM patients as all enrolled patients were
using insulin to control BG, which would influence
the total level of blood insulin. β cell function in
those with Qi and Yin deficiency syndrome was bet-
ter than that in the other two groups; however, there
seems to be a slight deviation in results when we use
the method of △Cp or the arginine test to assess β
cell function in those with Yin deficiency and inter-
nal Heat syndrome. There is a possibility that this re-
sults from toxicity of hyperglycemia, which might
suppress the response of the islet cells to sugar (carbo-
Beta cell function
FCp
30Cp
120Cp
△Cp30
△Cp120
Cp Index (n = 10)
INS Index (n = 10)
Group 1 (n = 42)
2.1±1.3
2.7±2.1
4.3±3.6
0.7±1.1
2.3±2.7
1.0±0.6
14.2±7.7
Group 2 (n = 25)
1.9±1.1
2.5±1.4
3.7±2.3
0.6±1.0
2.0±1.8
1.4±0.8
19.8±16.2
Group 3 (n = 42)
2.0±0.8
3.4±1.9
6.0±3.9ab
1.2±1.2b
3.7±3.2ab
1.9±0.9a
30.9±20.4a
Notes: group 1: intrinsic damp syndrome group, group 2: Yin deficiency and internal heat syndrome group, group 3: Qi deficiency and
Yin deficiency syndrome group. As the enrolled patients had a long duration of type 2 diabetes mellitus, all patients had been treated with
insulin; no patients were being treated with oral hypoglycemic drugs alone. Cp: C-peptide; FCp: fasting C-peptide; 30Cp: 30 min post-
prandial C-peptide; 120Cp: 120 min postprandial C-peptide; △Cp30: change in C-peptide after 30 min; △Cp120: change in C-peptide
after 120 min; INS: insulin. aP < 0.05, compared with group 1. bP < 0.05, compared with group 2.
Table 5 Beta cell function in each group (mU/L, xˉ ± s)
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hydrate) but not to amino acids, including arginine.18
In addition, Chinese diets are based mainly on carbo-
hydrates.
As well as higher glycemic variability, there was a high-
er mean BMI, TG and systolic blood pressure found in
those with intrinsic Damp syndrome. So BG, blood
lipid, and blood viscosity in Western Medicine might
be referred to as Damp turbidity in TCM.19 There was
no significant difference in TC, HDL-C and LDL-C
among groups; the reason for this may be that many
patients take statin drugs to control cholesterol levels as
more attention has been paid to this indicator since the
harms of cholesterol (especially LDL-C) on human
health are extensively known. In contrast, TG, which
has little relationship with DM complications, is al-
ways neglected.
There was no difference in HBA1C and GA between
those with intrinsic Damp syndrome and those with
Qi and Yin deficiency syndrome, although the MBG
in those with intrinsic Damp syndrome was higher
than that in those with Qi and Yin deficiency syn-
drome. The phenomenon referred above indicated that
the MBG might have some relationship with BMI,
which is associated with hepatic metabolism and chron-
ic inflammation.20 This was confirmed in our study by
measuring the plasma ALT, a data reflecting hepatic
metabolism; the ALT in those with intrinsic Damp syn-
drome was much lower than that in those with Qi and
Yin deficiency syndrome. Furthermore, we also found
that fewer patients with Yin deficiency and internal
Heat syndrome were treated with metformin compared
with those with intrinsic Damp syndrome, which can
be explained by the lower BMI of patients with Yin de-
ficiency and internal Heat syndrome. Since metformin
can take a more important part in losing weight,21 it
will not be firstly considered if patients had a lower
BMI.
Our results regarding BG fluctuations and β cell func-
tion indicate that different TCM syndromes might re-
flect the onset of T2DM, which is contrary to the con-
clusions of Duan et al.22 Qi and Yin deficiency syn-
drome is the foundation of T2DM, as reported in the
ancient literature. For example, the Ling Shu 'Wu Bian'
states that individuals with deficiency in the five
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Figure 1 Blood glucose profile of type 2 diabetes mellitus patients with three different Traditional Chinese Medicine syndromes
A: blood glucose profile of a patient with intrinsic Damp syndrome. B: blood glucose profile of a patient with Yin deficiency and in-
ternal Heat syndrome. C: blood glucose profile of a patient with Qi deficiency and Yin deficiency syndrome. The red horizontal
dotted line shows the hyperglycemia level (10.0 mmol/L), and the blue horizontal dotted line shows the hypoglycemic level (3.9
mmol/L). The "2" indicate the times when the CGMS was calibrated by entering capillary blood glucose readings measured using
a SureStep blood glucose meter.
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Zang organs are susceptible to xiaodan.23 The Ling
Shu 'Xie Qi Zang Fu Xing' also states that subjects
with weak pulse of the five Zang organs were all xiao-
dan, declaring that people with deficiency of the five
Zang organs and both Qi and Blood shortage were
susceptible to the disease.24 Above all, deficiency is
the base of DM, which is also a saying from the
Huang Di Nei Jing8 consistent with our conclusions.
Yet the disease can develop from the Qi and Yin defi-
ciency stage into the intrinsic Damp stage or Yin de-
ficiency and internal Heat stage, developing an orien-
tation that is closely associated with patients' physical
constitution and their eating habits. It is explained in
the Su Wen 'Qi Bing Lun' that most obese people
must have eaten too much sweet and fatty food. In-
ternal Heat generated by fatty food, and abdominal
distention induced by sweet food make ascending Qi
form DM8; this emphasizes the importance of diet in
the occurrence of DM.
However, not every patient will begin with deficiency
and go through all stages of the disease, as DM is a
disease closely related to the individuals' constitution.
Therefore, in clinical TCM practice, individualized
classification of patients should be based on the pa-
tient's own BG profile and clinical symptoms.
Heat-clearing herbs should be prescribed if the MBG
is high, but when the BG fluctuation is patent, herbs
with the effect of nourishing Yin and clearing Heat
or invigorating the Spleen and eliminating Dampness
can be chosen. Additionally, methods of supplement-
ing Qi, nourishing Yin, and activating Blood circula-
tion can be used to delay the incidence of complica-
tions when the BG profile is relatively stable.
In this study we explored the characteristics of glyce-
mic variability of T2DM in patients with Qi and Yin
deficiency syndrome, Yin deficiency and internal
Heat syndrome, and intrinsic Damp syndrome. This
information can lay the foundation for diagnosis and
treatment of T2DM in TCM, and provide data for
further research. However, there are several limita-
tions of this study. We only selected three common
syndromes with a small sample size, we did not re-
cord the use of antihypertensive drugs, and we only
analyzed fluctuations of BG but without exploring
other laws about BG level such as characteristics of
BG in the daytime and at night. Moreover, we only
chose T2DM patients already in treatment, and did
not include newly diagnosed patients or those with
impaired glucose tolerance (IGT). In addition, the
clamp test was not done to accurately assess the pan-
creatic islet function of patients. Further detailed pro-
spective studies into the characteristics of BG profiles
in newly diagnosed T2DM and IGT patients with a
large sample size are needed to provide information
on syndrome differentiation and selection of prescrip-
tions in clinical TCM practice.
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